Inovio Pharmaceuticals (INO) AGM 2026 summary

Opening remarks and agenda

• Meeting convened virtually with all directors and key officers present, confirming quorum and opening business.

• Agenda included election of directors, ratification of auditors, executive compensation, and incentive plan amendment.

Board and executive committee updates

• Eight directors nominated and elected to serve until the next annual meeting.

Shareholder proposals

• Proposals included election of directors, ratification of Ernst & Young LLP as auditors, advisory approval of executive compensation, and amendment of the 2023 Omnibus Incentive Plan.